National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 4 of 4 Research Studies DisplayedEaton EF, Kulczycki A, Saag M
Immunization costs and programmatic barriers at an urban HIV clinic.
This study estimated costs of providing Gardasil, Prevnar, and Zostavax to eligible patients at a US Ryan White Part C academically affiliated HIV clinic in 2013. Its cost analysis of 3 vaccines showed great variation in insurance coverage, with potential losses of almost $100 000 for one HIV clinic if eligible patients received vaccinations in one calendar year.
AHRQ-funded; HS013852.
Citation: Eaton EF, Kulczycki A, Saag M .
Immunization costs and programmatic barriers at an urban HIV clinic.
Clin Infect Dis 2015 Dec;61(11):1726-31. doi: 10.1093/cid/civ637.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Healthcare Costs, Medication, Vaccination
Lee BY, Bartsch SM, Mvundura M
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.
The researchers utilized a susceptible-exposed-infectious-recovered transmission model linked to an economic influenza outcomes model to assess the economic value of introducing the microneedle patch (MNP) into the U.S. influenza vaccine market from the third-party payer and societal perspectives. They concluded that if healthcare providers administered the MNP, its introduction would be less costly and more effective in the majority of scenarios assessed.
AHRQ-funded; HS023317.
Citation: Lee BY, Bartsch SM, Mvundura M .
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.
Vaccine 2015 Sep 08;33(37):4727-36. doi: 10.1016/j.vaccine.2015.02.076.
.
.
Keywords: Healthcare Delivery, Healthcare Costs, Influenza, Vaccination
Haidari LA, Wahl B, Brown ST
One size does not fit all: the impact of primary vaccine container size on vaccine distribution and delivery.
The researchers examined the questions of how the design of the primary container may affect the distribution of the vaccine, its resulting cost, and whether the vial is ultimately opened. Using a simulation model, they determined that when choosing a primary vaccine container, the choice depends on characteristics of the vaccine, the vaccine supply chain, immunization session size, and goals of decision makers. In fact, the optimal vial size may vary among locations within a country.
AHRQ-funded; HS023317.
Citation: Haidari LA, Wahl B, Brown ST .
One size does not fit all: the impact of primary vaccine container size on vaccine distribution and delivery.
Vaccine 2015 Jun 22;33(28):3242-7. doi: 10.1016/j.vaccine.2015.04.018..
Keywords: Healthcare Costs, Vaccination
Lee BY, Bartsch SM, Brown ST
Quantifying the economic value and quality of life impact of earlier influenza vaccination.
This study quantifies the potential benefits and cost-savings of vaccinating against influenza earlier than current practice. It found that, depending on the timing of the influenza season peak, influenza transmissibility, and preexisting immunity, vaccinating those who typically receive the vaccine later by the end of September could avert up to $3.7 million in direct costs, and $10.7 million in productivity losses.
AHRQ-funded; HS023317.
Citation: Lee BY, Bartsch SM, Brown ST .
Quantifying the economic value and quality of life impact of earlier influenza vaccination.
Med Care 2015 Mar;53(3):218-29. doi: 10.1097/mlr.0000000000000302..
Keywords: Vaccination, Influenza, Healthcare Costs